This process is fostered by the overexpression of specific chemokine receptors in bone-homing tumor cells, namely C-X-C motif chemokine receptor 4 (CXCR-4), which is normally expressed in hematopoietic stem cells (HSCs). This evidence concerns the gene CXCR4 and neoplasm.